Summary
- Current Price
- As of today, MDT price is $80.33, up +0.10% on
- Current Price All-Time High
- MDT price is currently -40.89% below its historical high of $135.89 set on
- Market Cap
- MDT current market cap is $103B, down -8.64% year-over-year
- PE Ratio
- MDT current PE ratio is 21.59
- Revenue
- MDT current annual revenue is $36.36B, up +8.43% year-over-year
- Next Earnings
- The next earnings release for MDT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Medtronic plc |
| Ticker | NYSE: MDT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | Ireland |
| IPO | |
| Indexes | |
| Website | medtronic.com |
| Employees | 95,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $80.33 | |
| Price, 1D Change | +0.10% | |
| Market Cap | $103B | |
| TTM Dividend Yield | 3.54% | |
| PE Ratio | 21.59 | |
| Beta | 0.31 | |
| Revenue | $36B | |
| Revenue, 1Y Change | +8.43% | |
| EPS | $3.73 | |
| EPS, 1Y Change | +3.20% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.71 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.73 | |
| EPS Estimate | N/A | $5.95 |
| EPS Est. Change | N/A | +59.46% |
| Revenue | $36.36B | |
| Revenue Estimate | N/A | $38.82B |
| Revenue Est. Change | N/A | +6.77% |
| Current Price | $80.33 | |
| Price Target | - | $101.50 |
| Price Tgt. Change | - | +26.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.46 | $3.61 | -33.75% | |
| $5.53 | $3.73 | -32.54% | |
| $5.95 | N/A | +59.46% | |
| $6.42 | N/A | +72.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $33.49B | $33.54B | +0.14% | |
| $36.12B | $36.36B | +0.67% | |
| $38.82B | N/A | +6.77% | |
| $40.07B | N/A | +10.20% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -8.78% | |
| Price, 3Y | -4.06% | |
| Market Cap, 1Y | -8.64% | |
| Market Cap, 3Y | -7.44% | |
| Revenue, 1Y | +8.43% | |
| Revenue, 3Y | +16.45% | |
| EPS, 1Y | +3.20% | |
| EPS, 3Y | +32.29% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $80.33 | |
| SMA 200 | $92.23 | |
| SMA 50 | $80.83 | |
| EMA 200 | $88.58 | |
| EMA 50 | $81.22 | |
| MACD | $0.13 | |
| Beta | 0.31 | |
| ATR | $1.92 | |
| 14-Day RSI | 53.77 | |
| 10-Day Volatility | 43.77% | |
| 1-Year Volatility | 21.11% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.71 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.54% | |
| Total Dividend | $2.84 | |
| Dividends Paid | $3.64B | |
| Payout Ratio | 75.23% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $36.36B | |
| EPS | $3.73 | |
| Gross Profit | $22.00B | |
| Gross Margin | 60.51% | |
| Operating Income | $7.53B | |
| Operating Margin | 20.70% | |
| Net Income | $4.84B | |
| Net Margin | 13.30% | |
| EBITDA | $10.48B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | - | |
| Current Ratio | - | |
| Quick Ratio | - | |
| - | ||
| Piotroski F-Score | - | |
| Altman Z-Score | - |
Valuations
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | - | |
| Cash & Equivalents | - | |
| Total Assets | - | |
| Current Assets | - | |
| Total Liabilities | - | |
| Current Liabilities | - | |
| Total Debt | $0.00 | |
| Short Term Debt | - | |
| Accounts Payable | - |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $31.56B | |
| Operating Expenses | $14.48B | |
| Cost Of Goods Sold | $14.36B | |
| SG&A | $0.00 | |
| D&A | $2.96B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.30B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $7.33B | |
| CFI | -$2.93B | |
| CFF | -$4.75B | |
| Capex | $1.90B | |
| Free Cash Flow | $5.43B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Goldman Sachs | → | |
| Bernstein | → | |
| Wells Fargo | → | |
| UBS | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| Leerink Partners | → | |
| BTIG | → | |
| Baird | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with MDT
FAQ
What is the ticker symbol for Medtronic plc?
The ticker symbol for Medtronic plc is NYSE:MDT
Does Medtronic plc pay dividends?
Yes, Medtronic plc pays dividends. The last payment was $0.71, with an ex-dividend date on March 26, 2026
What sector is Medtronic plc in?
Medtronic plc is in the Healthcare sector
What industry is Medtronic plc in?
Medtronic plc is in the Medical Devices industry
What country is Medtronic plc based in?
Medtronic plc is headquartered in Ireland
When did Medtronic plc go public?
Medtronic plc initial public offering (IPO) was on May 2, 1973
Is Medtronic plc in the S&P 500?
Yes, Medtronic plc is included in the S&P 500 index
Is Medtronic plc in the NASDAQ 100?
No, Medtronic plc is not included in the NASDAQ 100 index
Is Medtronic plc in the Dow Jones?
No, Medtronic plc is not included in the Dow Jones index
When was Medtronic plc last earnings report?
Medtronic plc's most recent earnings report was on June 3, 2026
When does Medtronic plc report earnings?
The next expected earnings date for Medtronic plc is August 18, 2026
Data Sources & References
- MDT Official Website www.medtronic.com
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- MDT Profile on Yahoo Finance finance.yahoo.com/quote/MDT
- MDT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdt